Genworth Financial Inc (GNW) concluded trading on Thursday at a closing price of $7.55, with 2.77 million shares of worth about $20.95 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 20.22% during that period and on December 05, 2024 the price saw a loss of about -0.79%. Currently the company’s common shares owned by public are about 428.43M shares, out of which, 418.58M shares are available for trading.
Stock saw a price change of -3.08% in past 5 days and over the past one month there was a price change of 15.09%. Year-to-date (YTD), GNW shares are showing a performance of 13.02% which increased to 22.96% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.67 but also hit the highest price of $7.90 during that period. The average intraday trading volume for Genworth Financial Inc shares is 2.77 million. The stock is currently trading 0.59% above its 20-day simple moving average (SMA20), while that difference is up 5.68% for SMA50 and it goes to 15.06% higher than SMA200.
Genworth Financial Inc (NYSE: GNW) currently have 428.43M outstanding shares and institutions hold larger chunk of about 85.20% of that.
The stock has a current market capitalization of $3.22B and its 3Y-monthly beta is at 0.99. PE ratio of stock for trailing 12 months is 36.94, while it has posted earnings per share of $0.20 in the same period. It has a debt-to-equity ratio of 0.19. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GNW, volatility over the week remained 1.69% while standing at 2.13% over the month.
Stock’s fiscal year EPS is expected to rise by 827.78% while it is estimated to increase by 7.78% in next year.
Coverage by Compass Point stated Genworth Financial Inc (GNW) stock as a Buy in their note to investors on May 05, 2016, suggesting a price target of $5.25 for the stock. On February 08, 2016, Compass Point Reiterated their recommendations, while on November 17, 2015, Goldman Initiated their ratings for the stock with a price target of $5. Stock get a Sell rating from UBS on November 04, 2015.
